표준 IV 투여 세트 시장 규모 : 제품 유형별, 최종 사용자별, 지역별 및 예측별

Global Standard IV Administration Sets Market Overview

The standard IV administration sets market refers to the segment of the medical devices industry focused on the production, distribution, and use of intravenous administration sets designed to deliver fluids, medications, blood products, and nutritional solutions directly into a patient's bloodstream. These medical devices typically consist of tubing, a drip chamber, a flow regulator, connectors, and sometimes filters that help control the safe and accurate flow of intravenous fluids. Standard IV administration sets are widely used in hospitals, clinics, ambulatory surgical centers, and home healthcare settings for routine medical treatments and infusion therapies.

Market growth is supported by increasing hospital admissions, rising surgical procedures, and the growing need for intravenous therapies in the treatment of chronic diseases and emergency conditions. Expansion of healthcare infrastructure, improvements in medical facilities, and the rising number of outpatient treatment centers are also contributing to higher demand for IV administration sets. As healthcare systems continue to expand and focus on efficient patient care, the use of reliable and sterile IV infusion equipment remains an important part of clinical treatment across global healthcare settings.

Market size -VMR Analyst Corridor Approach

A revenue convergence corridor is emerging across recent global assessments instead of relying on a single-point estimate. Market value is consolidating around USD 4.0 Billion in 2025, while long-term projections are extending toward USD 5.9 Billion by 2033, reflecting mid- to high-single-digit growth momentum. A CAGR of 5.5 % is being recorded over the forecast period (2027-2033), underscoring the market's structurally resilient growth trajectory.

Global Standard IV Administration Sets Market Definition

The standard IV administration sets market refers to the commercial ecosystem surrounding the production, distribution, and use of intravenous administration sets designed for delivering fluids, medications, blood products, and nutritional solutions directly into the bloodstream. These medical devices are commonly composed of components such as tubing, drip chambers, flow regulators, connectors, and filters that help ensure controlled and sterile fluid delivery during medical treatment. The market includes various types of IV administration sets used across hospitals, clinics, ambulatory surgical centers, and home healthcare settings.

Market dynamics involve procurement by healthcare institutions such as hospitals, specialty clinics, surgical centers, and home care providers that rely on IV administration sets for routine patient treatment and infusion therapies. The supply chain includes medical device manufacturers, raw material suppliers, distributors, and healthcare equipment providers responsible for delivering these products to healthcare facilities. Distribution channels typically involve hospital procurement systems, medical device distributors, and healthcare supply companies that ensure the continuous availability of IV administration sets for clinical use across global healthcare markets.

Global Standard IV Administration Sets Market Drivers

The market drivers for the standard IV administration sets market can be influenced by various factors. These may include:

Rising Demand for Intravenous Therapy in Healthcare Facilities

Increasing use of intravenous therapy in hospitals and clinical settings is supporting demand for standard IV administration sets. These devices are widely used for delivering fluids, medications, blood products, and nutritional solutions directly into the bloodstream. The growing number of hospital admissions, emergency treatments, and surgical procedures is contributing to higher usage of IV infusion systems. As healthcare providers continue to rely on efficient fluid delivery systems for patient care, the demand for standard IV administration sets is steadily increasing.

Expansion of Healthcare Infrastructure and Hospital Networks

The expansion of healthcare infrastructure across developing and developed regions is contributing to the growth of the standard IV administration sets market. Governments and private healthcare providers are investing in new hospitals, clinics, and surgical centers to improve access to medical services. These healthcare facilities require a consistent supply of IV administration sets for routine treatments and patient management. The growth of private hospitals and specialty care centers is further supporting the use of IV infusion equipment.

Rising Prevalence of Chronic Diseases and Surgical Procedures

The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is leading to greater demand for intravenous medication and fluid therapy. Many patients require IV treatment for medication delivery, chemotherapy, or supportive care during hospitalization. Additionally, the rising number of surgical procedures and emergency medical treatments is driving the use of IV administration sets for anesthesia delivery and fluid management. This growing need for clinical treatment is supporting market expansion.

Growth of Ambulatory Care and Home Healthcare Services

The growing adoption of ambulatory care and home healthcare services is creating additional demand for standard IV administration sets. Patients are increasingly receiving treatments such as antibiotic therapy, hydration therapy, and nutritional infusion outside traditional hospital settings. Ambulatory surgical centers and home care providers require reliable IV administration systems for safe and efficient treatment delivery. The shift toward outpatient care and cost-effective healthcare services is contributing to increasing usage of IV administration sets in non-hospital settings.

Global Standard IV Administration Sets Market Restraints

Several factors act as restraints or challenges for the standard IV administration sets market. These may include:

High Production and Material Costs

The manufacturing of standard IV administration sets requires medical-grade materials, sterile production environments, and strict quality control procedures. Components such as tubing, drip chambers, filters, and connectors must meet healthcare safety standards, which can increase production expenses. In addition, sterilization, packaging, and regulatory compliance add further operational costs for manufacturers. These cost factors can influence product pricing and may create challenges for smaller manufacturers operating with limited production capacity.

Strict Regulatory and Quality Compliance Requirements

Medical devices such as IV administration sets must comply with strict regulatory standards before entering the healthcare market. Regulatory authorities require manufacturers to follow detailed quality assurance processes, product testing, and certification procedures to ensure patient safety. Compliance with regulations in different countries may involve additional documentation, audits, and approval timelines. These regulatory requirements can increase operational burdens for manufacturers and may slow product entry into certain markets.

Risk of Product Contamination and Infection Concerns

Improper handling or manufacturing defects in IV administration sets can increase the risk of contamination or infection during intravenous therapy. Healthcare facilities must follow strict sterilization and usage protocols to minimize these risks. Concerns related to hospital-acquired infections can influence purchasing decisions and require healthcare providers to adopt higher-quality or advanced IV systems. Manufacturers must maintain strict safety standards to prevent complications associated with intravenous treatment.

Environmental Concerns Related to Medical Plastic Waste

Standard IV administration sets are generally designed for single use to maintain sterility and patient safety. As a result, healthcare facilities generate a large volume of plastic medical waste after each procedure. Growing concerns regarding environmental sustainability and medical waste management are placing pressure on healthcare providers and manufacturers. The need for proper disposal systems and environmentally responsible materials may increase operational costs and create challenges for the wider adoption of traditional plastic-based IV sets.

Global Standard IV Administration Sets Market Opportunities

he landscape of opportunities within the standard IV administration set market is driven by several growth-oriented factors and shifting global demands. These may include:

Increasing Demand for Intravenous Therapy in Medical Treatments

The growing use of intravenous therapy in hospitals and healthcare facilities is creating opportunities for the standard IV administration sets market. IV therapy is widely used for fluid replacement, medication delivery, blood transfusions, and nutritional support in patients undergoing medical treatment. The increasing number of hospital admissions and emergency care cases is contributing to greater use of IV infusion systems. As healthcare providers continue to depend on efficient intravenous delivery methods, the demand for standard IV administration sets is expected to increase.

Growth of Ambulatory Surgical Centers and Outpatient Care

The expansion of ambulatory surgical centers and outpatient care services is creating additional demand for IV administration sets. Many minor surgical procedures and treatments are now performed in outpatient facilities where intravenous fluids and medications are required. These healthcare centers rely on safe and efficient infusion systems to support patient care during procedures. The growing preference for shorter hospital stays and cost-effective treatment options is encouraging the use of IV administration sets in ambulatory care settings.

Expansion of Home Healthcare and Infusion Therapy Services

The rising adoption of home healthcare services is opening new opportunities for the standard IV administration sets market. Patients requiring long-term therapies such as antibiotic infusion, nutritional support, or hydration therapy are increasingly receiving treatment at home. Home healthcare providers require reliable and easy-to-use IV administration systems for safe therapy delivery. The shift toward patient-centered care and remote treatment solutions is contributing to growing demand for IV administration sets outside traditional hospital environments.

Advancements in Medical Device Manufacturing and Safety Features

Ongoing improvements in medical device manufacturing are supporting the development of safer and more efficient IV administration sets. Manufacturers are introducing features such as improved flow regulators, anti-backflow valves, and enhanced filtration components to support accurate fluid delivery. These improvements help reduce the risk of contamination and improve patient safety during intravenous therapy. Continuous product development and technological improvements are creating opportunities for manufacturers in the standard IV administration sets market.

Global Standard IV Administration Sets Market Segmentation Analysis

The Global Standard IV Administration Sets Market is segmented based on Product Type, End-User, and Geography.

Standard IV Administration Sets Market, By Product Type

Primary: The primary IV administration sets segment accounts for a large share of the market as these sets are widely used for direct intravenous fluid delivery in hospitals and clinical settings. These sets are designed to connect IV fluid containers to the patient's venous access device and are commonly used for hydration, medication infusion, and electrolyte administration. Their routine use in inpatient care, emergency treatment, and surgical procedures continues to support demand. Increasing hospital admissions, expansion of healthcare facilities, and rising need for efficient infusion therapy are supporting the steady growth of the primary IV administration sets segment.

Secondary: The secondary IV administration set segment is witnessing steady growth due to its role in intermittent medication infusion. These sets, often referred to as piggyback sets, allow secondary medications to be administered through an existing primary IV line without disconnecting the main infusion. This capability helps improve workflow efficiency and reduces the need for multiple venous access points. Hospitals and outpatient facilities are increasingly using secondary IV sets for antibiotic therapy and short-term medication delivery, contributing to the expansion of this segment.

Extension: The extension IV set is gaining traction as healthcare providers seek greater flexibility and safety in intravenous therapy. Extension sets are used to extend the distance between the patient and the primary IV line, helping reduce line movement and allowing easier patient mobility. These sets are commonly used in critical care units, neonatal care, and infusion therapy, where careful line management is required. Rising focus on patient comfort, infection control practices, and improved infusion system configurations is supporting demand for extension IV sets in healthcare facilities.

Standard IV Administration Sets Market, By End-User

Hospitals: The hospitals segment holds the largest share of the standard IV administration sets market due to the high volume of inpatient treatments and surgical procedures requiring intravenous therapy. Hospitals routinely administer fluids, medications, blood products, and nutritional solutions through IV infusion, which drives continuous demand for reliable administration sets. The presence of advanced healthcare infrastructure, skilled medical staff, and high patient inflow supports large-scale usage of IV sets. Rising hospital admissions related to chronic diseases, emergency care, and surgical interventions are also contributing to sustained demand in this segment.

Clinics: The clinics segment is witnessing steady growth as outpatient care services expand across many healthcare systems. Clinics commonly use IV administration sets for hydration therapy, antibiotic infusions, and minor medical treatments that do not require hospital admission. Increasing preference for cost-effective outpatient treatment and shorter patient visits is supporting the use of IV infusion in clinic settings. The growth of specialty clinics, including oncology and wellness clinics, is also contributing to the increasing consumption of standard IV administration sets.

Ambulatory Surgical Centers: The ambulatory surgical centers segment is gaining traction due to the rising number of same-day surgical procedures performed outside traditional hospitals. These facilities rely on IV administration sets for anesthesia delivery, fluid management, and medication infusion during surgical procedures. Ambulatory centers offer faster treatment, reduced hospital stays, and lower procedure costs, which are encouraging patients and healthcare providers to adopt these settings. The expansion of minimally invasive surgeries and outpatient surgical services is supporting demand for IV administration sets in ambulatory surgical centers.

Standard IV Administration Sets Market, By Geography

North America: North America holds a strong share of the standard IV administration sets market due to the presence of advanced healthcare infrastructure and high healthcare spending. Hospitals and surgical centers widely use IV administration sets for fluid therapy, medication delivery, and blood transfusion procedures. The region also benefits from the presence of major medical device manufacturers and well-established hospital networks. Rising cases of chronic diseases, increasing surgical procedures, and continuous adoption of advanced infusion technologies are supporting market growth across the United States and Canada.

Asia Pacific: Asia Pacific is witnessing rapid growth in the standard IV administration sets market as healthcare infrastructure expands across developing economies. Countries such as China, India, Japan, and South Korea are experiencing rising hospital admissions and increasing demand for intravenous therapies. Government investments in healthcare facilities, improving access to medical treatment, and growing patient populations are supporting demand for IV administration sets. The expansion of private hospitals and diagnostic centers is also contributing to market growth in the region.

Europe: Europe accounts for a considerable share of the standard IV administration sets market due to well-developed healthcare systems and widespread access to medical services. Hospitals and outpatient care centers regularly utilize IV administration sets for medication infusion, hydration therapy, and surgical care. Countries such as Germany, the United Kingdom, and France have strong healthcare infrastructure and a high number of medical procedures. Increasing elderly populations and the prevalence of chronic illnesses are also contributing to steady demand across the region.

Latin America: Latin America is experiencing moderate growth in the standard IV administration sets market as healthcare systems continue to expand. Countries including Brazil, Mexico, and Argentina are increasing investments in hospitals and medical equipment to improve patient care services. Rising demand for intravenous therapies in emergency care, surgery, and chronic disease management is supporting the use of IV administration sets. Growth in private healthcare facilities and improving access to medical treatments are also contributing to market expansion.

Middle East & Africa: The Middle East & Africa region is witnessing gradual growth in the standard IV administration sets market as healthcare infrastructure improves across several countries. Nations such as the UAE, Saudi Arabia, and South Africa are expanding hospital networks and investing in advanced medical technologies. Increasing healthcare awareness, rising hospital admissions, and government initiatives aimed at strengthening healthcare systems are contributing to the demand for IV administration sets in the region.

Key Players

• The competitive environment is remaining brand-driven, with established players leveraging distribution scale, product breadth, and brand trust. Competitive differentiation is shifting toward material transparency, comfort-led design, and sustainability positioning, while portfolio consolidation and brand acquisition activity are reshaping ownership dynamics.
• Key Players Operating in the Global Standard IV Administration Sets Market
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• Baxter International Inc.
• Fresenius Kabi AG
• ICU Medical, Inc.
• Terumo Corporation
• Moog Inc.
• Smiths Medical, Inc.
• Vygon SA
• Market Outlook and Strategic Implications
• Growth momentum is remaining stable, while strategic focus is increasingly prioritizing compliance readiness, premiumization, and consumer trust reinforcement. Investment allocation is shifting toward scalable innovation and lifecycle value, as transparency, safety assurance, and access expansion are emerging as long-term competitive differentiators.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 MARKET DEFINITION
• 1.2 MARKET SEGMENTATION
• 1.3 RESEARCH TIMELINES
• 1.4 ASSUMPTIONS
• 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

• 2.1 DATA MINING
• 2.2 SECONDARY RESEARCH
• 2.3 PRIMARY RESEARCH
• 2.4 SUBJECT MATTER EXPERT ADVICE
• 2.5 QUALITY CHECK
• 2.6 FINAL REVIEW
• 2.7 DATA TRIANGULATION
• 2.8 BOTTOM-UP APPROACH
• 2.9 TOP-DOWN APPROACH
• 2.10 RESEARCH FLOW
• 2.11 DATA SOURCES

3 EXECUTIVE SUMMARY

• 3.1 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET OVERVIEW
• 3.2 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET ESTIMATES AND FORECAST (USD BILLION)
• 3.3 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET ECOLOGY MAPPING
• 3.4 COMPETITIVE ANALYSIS: FUNNEL DIAGRAM
• 3.5 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET ABSOLUTE MARKET OPPORTUNITY
• 3.6 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET ATTRACTIVENESS ANALYSIS, BY REGION
• 3.7 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET ATTRACTIVENESS ANALYSIS, BY PRODUCT TYPE
• 3.8 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET ATTRACTIVENESS ANALYSIS, BY END-USER
• 3.9 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
• 3.10 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET, BY PRODUCT TYPE (USD BILLION)
• 3.11 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET, BY END-USER (USD BILLION)
• 3.12 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET, BY GEOGRAPHY (USD BILLION)
• 3.13 FUTURE MARKET OPPORTUNITIES

4 MARKET OUTLOOK

• 4.1 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET EVOLUTION
• 4.2 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET OUTLOOK
• 4.3 MARKET DRIVERS
• 4.4 MARKET RESTRAINTS
• 4.5 MARKET TRENDS
• 4.6 MARKET OPPORTUNITY
• 4.7 PORTER'S FIVE FORCES ANALYSIS
  • 4.7.1 THREAT OF NEW ENTRANTS
  • 4.7.2 BARGAINING POWER OF SUPPLIERS
  • 4.7.3 BARGAINING POWER OF BUYERS
  • 4.7.4 THREAT OF SUBSTITUTE USER PRODUCT TYPES
  • 4.7.5 COMPETITIVE RIVALRY OF EXISTING COMPETITORS
• 4.8 VALUE CHAIN ANALYSIS
• 4.9 PRICING ANALYSIS
• 4.10 MACROECONOMIC ANALYSIS

5 MARKET, BY PRODUCT TYPE

• 5.1 OVERVIEW
• 5.2 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY PRODUCT TYPE
• 5.3 PRIMARY
• 5.4 SECONDARY
• 5.5 EXTENSION SETS

6 MARKET, BY END-USER

• 6.1 OVERVIEW
• 6.2 GLOBAL STANDARD IV ADMINISTRATION SETS MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY END-USER
• 6.3 HOSPITALS
• 6.4 CLINICS
• 6.5 AMBULATORY SURGICAL CENTERS

7 MARKET, BY GEOGRAPHY

• 7.1 OVERVIEW
• 7.2 NORTH AMERICA
  • 7.2.1 U.S.
  • 7.2.2 CANADA
  • 7.2.3 MEXICO
• 7.3 EUROPE
  • 7.3.1 GERMANY
  • 7.3.2 U.K.
  • 7.3.3 FRANCE
  • 7.3.4 ITALY
  • 7.3.5 SPAIN
  • 7.3.6 REST OF EUROPE
• 7.4 ASIA PACIFIC
  • 7.4.1 CHINA
  • 7.4.2 JAPAN
  • 7.4.3 INDIA
  • 7.4.4 REST OF ASIA PACIFIC
• 7.5 LATIN AMERICA
  • 7.5.1 BRAZIL
  • 7.5.2 ARGENTINA
  • 7.5.3 REST OF LATIN AMERICA
• 7.6 MIDDLE EAST AND AFRICA
  • 7.6.1 UAE
  • 7.6.2 SAUDI ARABIA
  • 7.6.3 SOUTH AFRICA
  • 7.6.4 REST OF MIDDLE EAST AND AFRICA

8 COMPETITIVE LANDSCAPE

• 8.1 OVERVIEW
• 8.2 KEY DEVELOPMENT STRATEGIES
• 8.3 COMPANY REGIONAL FOOTPRINT
• 8.4 ACE MATRIX
  • 8.5.1 ACTIVE
  • 8.5.2 CUTTING EDGE
  • 8.5.3 EMERGING
  • 8.5.4 INNOVATORS

9 COMPANY PROFILES

• 9.1 OVERVIEW
• 9.2 BECTON, DICKINSON AND COMPANY
• 9.3 B. BRAUN MELSUNGEN AG
• 9.4 BAXTER INTERNATIONAL INC.
• 9.5 FRESENIUS KABI AG
• 9.6 ICU MEDICAL, INC.
• 9.7 TERUMO CORPORATION
• 9.8 MOOG INC.
• 9.9 SMITHS MEDICAL, INC.
• 9.10 VYGON SA